Effektivitas dan Biaya pada Terapi Pasien Diabetes Mellitus Tipe 2 Rawat Jalan di Rumah Sakit Umum Denpasar

Therapy guidelines for patients with type 2 diabetes mellitus emphasize the need for a personal approach in the choose of drug therapy for each patient. This has an implication for the emergence of different therapeutic groups in the treatment of type 2 diabetes mellitus. The purpose of this study is to determine the therapeutic groups of treatment in type 2 diabetes mellitus patients, the total cost therapy, the therapy effectiveness and the ratio between the two. This research is a prospective descriptive study in diabetes mellitus outpatients in Denpasar general hospital which is followed for 3 months continuously. There were 34 patients who met the inclusion and exclusion criteria of the study which were divided into 7 large groups of antidiabetic therapy. The effectiveness of antidiabetic therapy ranges from 11.11% to 66.66%. The total range of antidiabetic therapy costs ranges from IDR. 548,094 up to IDR. 3,274,372. The therapy group with the lowest cost-per-percent effectiveness ratio was metformin and glimepiride combination therapy with the cost of IDR. 19,184 /% effectiveness and the highest was the combination therapy of Insulin Aspart and Insulin Glargine which was IDR 261,882 /% effectiveness.